Cardio Diagnostics Holdings (CDIO) EBIT Growth (3y) (2024 - 2026)
Cardio Diagnostics Holdings (CDIO) EBIT Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | 69.02% |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | 24.14% |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 44.54% |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 44.34% |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | -28.30% |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 81.27% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -18.82% |
| 10 | Cardio Diagnostics Holdings | 6.07 Mn | 480,214.31 | - | 16.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.28% |
| Mar 31, 2026 | -1.57% |
| Dec 31, 2025 | 14.95% |
| Sep 30, 2025 | -14.15% |
| Jun 30, 2025 | -28.73% |
| Mar 31, 2025 | -92.92% |
| Dec 31, 2024 | -118.52% |
| Sep 30, 2024 | -1,150.23% |
| Jun 30, 2024 | -1,378.26% |